MetLife Investment Management, LLC
Position in EDIT — Editas Medicine, Inc.
CIK 1529735
Whippany, NJ
Position in EDIT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$104,809
+$69,914 QoQ
Shares Held
42,433
+149.3% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $374,315,342 across 207 Biotechnology names. EDIT ranks #189 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
70,804 | $31,616,818 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
80,930 | $26,074,836 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
152,645 | $25,800,057 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
374,931 | $24,231,790 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,567 | $18,208,806 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
1,805,184 | $17,004,833 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,738,062 | $15,659,938 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
708,527 | $13,858,788 |
All Filings in EDIT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $104,809 | 42,433 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $34,895 | 17,022 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $133,653 | 38,517 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $114,301 | 51,955 | Shares | Defined | 2025-08-13 | |
| 2024-09-30 | $100,656 | 29,518 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $220,680 | 47,255 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $286,085 | 38,556 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $441,576 | 43,591 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $340,009 | 43,591 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $305,728 | 37,148 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $269,323 | 37,148 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $329,502 | 37,148 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $454,691 | 37,148 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $439,460 | 37,148 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $706,554 | 37,148 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $626,633 | 23,602 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $969,570 | 23,602 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $1,413,054 | 24,948 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $1,047,816 | 24,948 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $1,749,104 | 24,948 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $748,332 | 26,669 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $732,164 | 24,752 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $426,701 | 21,518 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||